The reason that the share information doesn’t matter to me, is that it will get bought by one of the big 10 pharma companies."
Maybe there will be another chance After Data and movement to Phase 3 of IV or the start of enrollment or success of Inhaler Trials. 2 Inhaler Trials now so this must be their main focus and target for distribution. IV has logistic issues, IMVHO. They partnered In-House and are seeking Subs/contract work for distribution and inhaler production. Right?